Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952365 · ClinicalTrials.gov registry record · Phase 4
Tissue Sealant Use in LASIK Enhancement Surgery
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02952365: Completed Phase 4 study, sponsored by Stanford University.
NCT02952365 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02952365, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the use of prophylactic tissue sealant to prevent epithelial ingrowth from gaining access under a LASIK flap with repeat LASIK surgery
Primary Outcome
The number of eyes that developed epithelial ingrowth under LASIK flap
Interventions
- DRUG Tissue sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2017-05-22 |
| Phase | Phase 4 |
What the finished NCT02952365 record still lists
NCT02952365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Tissue sealant is the first listed.
NCT02952365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02952365 about?
NCT02952365 is a clinical study titled "Tissue Sealant Use in LASIK Enhancement Surgery". The purpose of the study is to evaluate the use of prophylactic tissue sealant to prevent epithelial ingrowth from gaining access under a LASIK flap with repeat LASIK surgery
What is the current status of trial NCT02952365?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2016-10-01. Estimated completion is 2017-05-22.
What interventions are being tested in trial NCT02952365?
The interventions under investigation include: Tissue sealant (DRUG).
Who is sponsoring clinical trial NCT02952365?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02952365's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI